Imidazo[1,2-a]pyridine compounds for use in treating cancer
US8513276B2 · kind B2 · utility
6Cited by
10References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2007 |
| Grant date | Aug 20, 2013 |
| Priority date | — |
| Expiry date | Aug 11, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to new bicyclic heterocyclic derivative compounds of Formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer. The compounds of Formula (I) are inhibitors of FGFR, VEGFR or PDGFR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.